Literature DB >> 16635535

Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M.

Khalid A Tazi1, Jean-Jacques Quioc, Véronique Saada, Annie Bezeaud, Didier Lebrec, Richard Moreau.   

Abstract

BACKGROUND/AIMS: In cirrhosis, tumor necrosis factor (TNF)-alpha overproduction is involved in both the systemic complications and progression of liver injury. Since monocytes from patients with advanced cirrhosis have an increase in lipopolysaccharide (LPS)-induced TNF-alpha production, we hypothesized that an upregulation of TNF-alpha production pathways and/or alteration of constitutive and inducible suppressor of TNF-alpha hyperproduction (protein kinase B (Akt) and interleukin-1 receptor-associated kinase (IRAK)-M, respectively) should be found in monocytes of these patients. Thus, we investigated ex vivo the signaling pathways of TNF-alpha production before and after LPS incubation in monocytes from noninfected Child-Pugh C patients with advanced cirrhosis and healthy subjects.
METHODS: TNF-alpha production, expressions of intracellular TNF-alpha, toll-like receptor-4 (TLR4), IkappaB-alpha, IRAK-1, IRAK-M, mitogen-activated protein (MAP) kinases and Akt activity were measured in monocytes.
RESULTS: Cirrhotic monocytes without LPS have less TLR4 expression, less IkappaB-alpha protein levels, more TNF-alpha expression, higher MAP kinase activities and decreased Akt activity than control monocytes. In cirrhotic monocytes, LPS-induced TNF-alpha hyperproduction and signaling upregulation were associated with a lack of IRAK-M induction.
CONCLUSIONS: Upregulated signaling pathways of the TNF-alpha production, decreased Akt activity and a lack of IRAK-M induction may be involved in the process of cirrhotic monocyte sensitization to produce TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16635535     DOI: 10.1016/j.jhep.2006.02.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  29 in total

1.  The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases.

Authors:  João-Bruno Soares; Pedro Pimentel-Nunes; Roberto Roncon-Albuquerque; Adelino Leite-Moreira
Journal:  Hepatol Int       Date:  2010-10-21       Impact factor: 6.047

Review 2.  Enhancement of dendritic cells as vaccines for cancer.

Authors:  Meghan E Turnis; Cliona M Rooney
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

3.  Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

Authors:  Ahmed Abu Shanab; Paul Scully; Orla Crosbie; Martin Buckley; Liam O'Mahony; Fergus Shanahan; Sanaa Gazareen; Eileen Murphy; Eamonn M M Quigley
Journal:  Dig Dis Sci       Date:  2010-11-03       Impact factor: 3.199

4.  The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes.

Authors:  Pranoti Mandrekar; Shashi Bala; Donna Catalano; Karen Kodys; Gyongyi Szabo
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  The burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in patients with cirrhosis.

Authors:  Richard Moreau
Journal:  Hepatol Int       Date:  2014-09-06       Impact factor: 6.047

6.  Tying up PGE2 with albumin to relieve immunosuppression in cirrhosis.

Authors:  Vicente Arroyo; Richard Moreau
Journal:  Nat Med       Date:  2014-05       Impact factor: 53.440

7.  IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity.

Authors:  Meghan E Turnis; Xiao-Tong Song; Adham Bear; Aaron E Foster; Stephen Gottschalk; Malcolm K Brenner; Si-Yi Chen; Cliona M Rooney
Journal:  J Immunol       Date:  2010-09-03       Impact factor: 5.422

8.  Dysfunction of Circulating Polymorphonuclear Leukocytes and Monocytes in Ambulatory Cirrhotics Predicts Patient Outcome.

Authors:  Konstantina Sargenti; Åsa Johansson; Sara Bertilsson; Inger Mattsby-Baltzer; Daniel Klintman; Evangelos Kalaitzakis
Journal:  Dig Dis Sci       Date:  2016-03-24       Impact factor: 3.199

9.  Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.

Authors:  Jinsheng Guo; Scott L Friedman
Journal:  Fibrogenesis Tissue Repair       Date:  2010-10-21

10.  Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury.

Authors:  Justin D Ellett; Zachary P Evans; Carl Atkinson; Michael G Schmidt; Rick G Schnellmann; Kenneth D Chavin
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.